Henk Tissing
Chief Tech/Sci/R&D Officer at ONCOSIL MEDICAL LIMITED
Profile
Henk Tissing is the Director & Global Head-Clinical Affairs at OncoSil Medical Ltd.
He previously worked as the Director-EMEA Clinical Affairs at Sirtex Medical Pty Ltd.
from 2012 to 2018 and as the VP-Clinical Development Interventional Oncology at BTG Ltd.
from 2018 to 2021.
Mr. Tissing received his undergraduate degree from the University of Leiden in 1991.
Henk Tissing active positions
Companies | Position | Start |
---|---|---|
ONCOSIL MEDICAL LIMITED | Chief Tech/Sci/R&D Officer | - |
Former positions of Henk Tissing
Companies | Position | End |
---|---|---|
BTG | Corporate Officer/Principal | 2021-03-31 |
SIRTEX MEDICAL LIMITED | Corporate Officer/Principal | 2018-08-31 |
Training of Henk Tissing
University of Leiden | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
ONCOSIL MEDICAL LIMITED | Health Technology |
Private companies | 2 |
---|---|
BTG Ltd.
BTG Ltd. Pharmaceuticals: MajorHealth Technology BTG Ltd. is a global healthcare company, which focuses on interventional medicine that can help physicians to treat patients through minimally invasive procedures. It operates through the following segments: Product, Licensing, and Other. The firm's products include CroFab, DigiFab, Voraxage. The company was founded on December 12, 1991 and is headquartered in Farnham, the United Kingdom. | Health Technology |
Sirtex Medical Pty Ltd.
Sirtex Medical Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Sirtex Medical Ltd. manufactures, and distributes liver cancer treatments. It operates through the following geographical segments: Asia Pacific, Americas, and Europe, Middle East, and Africa. It offers targeted radiation therapy known as SIR Spheres Y-90 resin microspheres. The company was founded in 1997 and is headquartered in St Leonards, Australia. | Commercial Services |
- Stock Market
- Insiders
- Henk Tissing